Epixone-TZ 500mg/62.5mg Injection
Marketer
Epitome Life Sciences
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Epixone-TZ 500mg/62.5mg Injection
Tazone-DX, a 500mg/62.5mg injectable combination drug, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be solely under a healthcare provider's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician about all concurrent medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving, avoid operation of vehicles if drowsiness or dizziness occur. Adequate rest, proper nutrition, and hydration contribute to faster recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Epixone-TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Epixone-TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Epixone-TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Epixone-TZ 500mg/62.5mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Epixone-TZ 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Epixone-TZ 500mg/62.5mg Injection, offer a potent antibacterial approach. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Epixone-TZ 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Epixone-TZ (500mg/62.5mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal to no negative consequences for fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
The administration of Epixone-TZ 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Epixone-TZ 500mg/62.5mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Epixone-TZ 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Epixone-TZ (500mg/62.5mg) requires careful administration in individuals with significant hepatic impairment. Dosage modification for Epixone-TZ (500mg/62.5mg) injection may be necessary; physician consultation is advised. Altering the dose of Epixone-TZ (500mg/62.5mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Epixone-TZ 500mg/62.5mg Injection :
Omit a scheduled Epixone-TZ 500mg/62.5mg Injection? Seek medical advice immediately.
Facts to Know About Epixone-TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently